Ligutom, Blenda .
HRN: 28-29-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2025
CEFTRIAXONE 1G (VIAL)
12/19/2025
12/19/2025
IV
2g
PTOR
Stat Cs
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines